Thiazolide antiparasitic
Nitazoxanide
Inhibits pyruvate:ferredoxin oxidoreductase (PFOR)–dependent electron transfer in anaerobic parasites; host antiviral effects have been investigated separately.
Primary Mechanism of Action
Clinical / Scientific
The active metabolite tizoxanide interferes with PFOR -dependent electron transfer used by some anaerobic protozoa and helminths. Broader in-vitro antiviral and inflammasome-related findings exist but are not automatically clinical indications.
Pathway Targets
Pyruvate:ferredoxin oxidoreductase
Scientific explanation
Disruption of anaerobic energy metabolism in susceptible parasites.
Pathway Convergence
Clinical / Scientific
Target → pathway → downstream effect → biological consequence. This is a mechanistic map, not a treatment claim.
Anaerobic energy block
Target to downstream effect: PFOR-dependent electron-transfer interference → Impaired parasite energy metabolism
Mechanistically Relevant Repurposed & Adjunctive Applications
Cryptosporidiosis and labelled protozoal infections
EstablishedMechanistic rationale
Established for labelled antiparasitic indications such as cryptosporidiosis and giardiasis where approved.
Investigational antiviral use
InvestigationalMechanistic rationale
Antiviral hypotheses are investigational; mechanism on a page is not proof of efficacy.
Mechanistic Application Matrix
| Biological Target | Mechanism | Potential Relevance | Evidence Level |
|---|---|---|---|
| PFOR | Electron-transfer interference | Anaerobic parasite metabolism | Established mechanism |
In Plain Language
Nitazoxanide interrupts a special energy pathway that some gut parasites use in low-oxygen environments.
Mechanistic information is provided for scientific and educational purposes. Discussion of biological pathways or investigational applications does not establish clinical efficacy or constitute individualized medical advice.